Parvin Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Parvin Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Sell	18,765 -50	-0.3%	-$2.92K	0.82%	36
2025 Q4	$1.01M	Buy	18,815 +5,990	+47%	+$288K	0.81%	37
2025 Q3	$578K	Buy	12,825 +5,490	+75%	+$256K	0.51%	62
2025 Q2	$340K	Sell	7,335 -100	-1%	-$4.91K	0.34%	83
2025 Q1	$453K	Buy	7,435 +35	+0.5%	+$2.04K	0.5%	66
2024 Q4	$419K	Buy	+7,400	New	+$413K	0.44%	69

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parvin Asset Management's BMY Position: Q1 2026 in Review

Parvin Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.27% in Q1 2026, selling an estimated $2.92K and leaving 18,765 shares worth $1.14M. The position accounts for 0.82% of the portfolio, ranked #36.

Parvin Asset Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Parvin Asset Management held 18,765 shares of Bristol-Myers Squibb worth $1.14M as of Q1 2026.
Parvin Asset Management sold 50 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.92K.
Bristol-Myers Squibb made up 0.82% of Parvin Asset Management's portfolio in Q1 2026, its #36 holding.
Parvin Asset Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Parvin Asset Management's 13F filing for Q1 2026, filed 18 May 2026.